Feverfew has been shown to be effective in numerous studies for migraine prevention. (rismedia.com)
«We look forward to further expanding our new product portfolio with the expected U.S. launch of Aimovig TM (erenumab), our first - in - class migraine prevention therapy, in the second quarter and the European launch of AMGEVITA TM (biosimilar adalimumab) our first biosimilar, later this year.» (cnbc.com)
To quantify the difference, a 2013 meta - analysis looked at placebo effects in 79 studies of migraine prevention: sugar pills reduced headache frequency for 22 percent of patients, fake acupuncture helped 38 percent, and sham surgery was a hit for a remarkable 58 percent. (scientificamerican.com)